Raphael Teipel

669 total citations
21 papers, 196 citations indexed

About

Raphael Teipel is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Raphael Teipel has authored 21 papers receiving a total of 196 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hematology, 10 papers in Oncology and 5 papers in Genetics. Recurrent topics in Raphael Teipel's work include Hematopoietic Stem Cell Transplantation (9 papers), CAR-T cell therapy research (7 papers) and Multiple Myeloma Research and Treatments (7 papers). Raphael Teipel is often cited by papers focused on Hematopoietic Stem Cell Transplantation (9 papers), CAR-T cell therapy research (7 papers) and Multiple Myeloma Research and Treatments (7 papers). Raphael Teipel collaborates with scholars based in Germany, United States and Chile. Raphael Teipel's co-authors include Martin Bornhäuser, Frank Kroschinsky, Johannes Schetelig, Malte von Bonin, Christian Thiede, Michael Krämer, Helmuth Schmidt, Kristina Hölig, Gerhard Ehninger and Uta Oelschlägel and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Raphael Teipel

18 papers receiving 196 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Raphael Teipel Germany	8	137	72	59	38	30	21	196
Kaiyang Ding China	9	107 0.8×	113 1.6×	100 1.7×	30 0.8×	46 1.5×	51	241
Sally Jeffries United Kingdom	6	183 1.3×	25 0.3×	66 1.1×	57 1.5×	21 0.7×	10	235
Nicole R. Grieselhuber United States	6	89 0.6×	38 0.5×	125 2.1×	19 0.5×	17 0.6×	22	202
H. Kreipe Germany	5	124 0.9×	28 0.4×	42 0.7×	48 1.3×	18 0.6×	13	172
Alex Elder United Kingdom	5	121 0.9×	58 0.8×	64 1.1×	18 0.5×	46 1.5×	12	207
Galina Tsykunova Norway	8	147 1.1×	30 0.4×	103 1.7×	25 0.7×	21 0.7×	25	200
Pentti Mäntymaa Finland	12	271 2.0×	127 1.8×	43 0.7×	26 0.7×	98 3.3×	31	332
Carmen Martínez‐Chamorro Spain	9	341 2.5×	173 2.4×	128 2.2×	43 1.1×	38 1.3×	15	383
Aline Clavert France	10	125 0.9×	55 0.8×	44 0.7×	86 2.3×	51 1.7×	23	225
Chiara Pavoni Italy	7	56 0.4×	33 0.5×	31 0.5×	38 1.0×	18 0.6×	18	117

Countries citing papers authored by Raphael Teipel

Since Specialization

Citations

This map shows the geographic impact of Raphael Teipel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raphael Teipel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raphael Teipel more than expected).

Fields of papers citing papers by Raphael Teipel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raphael Teipel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raphael Teipel. The network helps show where Raphael Teipel may publish in the future.

Co-authorship network of co-authors of Raphael Teipel

This figure shows the co-authorship network connecting the top 25 collaborators of Raphael Teipel. A scholar is included among the top collaborators of Raphael Teipel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raphael Teipel. Raphael Teipel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Holtick, Udo, Hyatt Balke‐Want, Sandra Sauer, et al.. (2025). Sequential BCMA CAR T-cell therapy in refractory multiple myeloma. Blood Advances. 9(18). 4624–4630.

Voorhees, Peter M., Anita D’Souza, Alfred Chung, et al.. (2024). Efficacy, safety, and determination of RP2D of ABBV-383, a BCMA bispecific antibody, in patients with relapsed/refractory multiple myeloma (RRMM).. Journal of Clinical Oncology. 42(16_suppl). 7531–7531. 8 indexed citations

Jambor, Helena, Malte von Bonin, Karolin Trautmann‐Grill, et al.. (2024). Communicating cancer treatment with pictogram-based timeline visualizations. Journal of the American Medical Informatics Association. 32(3). 480–491.

Weisel, Katja, Anita D’Souza, David D. Hurd, et al.. (2023). P862: A PHASE 1 FIRST-IN-HUMAN MONOTHERAPY STUDY OF ABBV-383, A BCMA × CD3 BISPECIFIC T-CELL–REDIRECTING ANTIBODY, IN RELAPSED/REFRACTORY MULTIPLE MYELOMA. HemaSphere. 7(S3). e0036307–e0036307. 1 indexed citations

Osterhoff, Georg, Michael Kreinest, Thomas Kuhnt, et al.. (2023). Management of Pathological Thoracolumbar Vertebral Fractures in Patients With Multiple Myeloma: Multidisciplinary Recommendations. Global Spine Journal. 13(1_suppl). 85S–93S. 2 indexed citations

Sockel, Katja, Friedrich Stölzel, Christoph Röllig, et al.. (2022). Allogeneic Stem Cell Transplantation with Sequential Melphalan-Based Conditioning in AML: Residual Morphological Blast Count Determines the Risk of Relapse. SHILAP Revista de lepidopterología. 3 indexed citations

Paiva, Bruno, Irene Manrique, Meletios Α. Dimopoulos, et al.. (2022). MRD dynamics during maintenance for improved prognostication of 1280 patients with myeloma in the TOURMALINE-MM3 and -MM4 trials. Blood. 141(6). 579–591. 25 indexed citations

Schetelig, Johannes, Friedrich Stölzel, Jan Moritz Middeke, et al.. (2022). Macroscopic, histologic, and clinical assessment of acute graft-versus-host disease of the upper gastrointestinal tract within 6 weeks after allogeneic hematopoietic cell transplantation. Experimental Hematology. 108. 36–45. 3 indexed citations

Paiva, Bruno, Irene Manrique, Meletios Α. Dimopoulos, et al.. (2022). P-052: Measurable residual disease (MRD) dynamics during maintenance with ixazomib vs placebo in 1280 newly diagnosed multiple myeloma (NDMM) patients: a pooled analysis of the TOURMALINE-MM3 and -MM4 trials. Clinical Lymphoma Myeloma & Leukemia. 22. S63–S64.

10.

Marten, Sandra, Raphael Teipel, Oliver Tiebel, & Karolin Trautmann‐Grill. (2022). Successful treatment of acquired von Willebrand syndrome in multiple myeloma. SHILAP Revista de lepidopterología. 7. 100108–100108. 1 indexed citations

11.

Heuschkel, Sandra, Raphael Teipel, Simone von Bonin, et al.. (2021). Half-dose glucarpidase as efficient rescue for toxic methotrexate levels in patients with acute kidney injury. Cancer Chemotherapy and Pharmacology. 89(1). 41–48. 6 indexed citations

12.

Bonin, Malte von, Helena Jambor, Raphael Teipel, et al.. (2021). Clonal hematopoiesis and its emerging effects on cellular therapies. Leukemia. 35(10). 2752–2758. 23 indexed citations

13.

Hölig, Kristina, Helmuth Schmidt, Gero Hütter, et al.. (2020). Salvage treatment with plerixafor in poor mobilizing allogeneic stem cell donors: results of a prospective phase II-trial. Bone Marrow Transplantation. 56(3). 635–645. 11 indexed citations

14.

Krüger, Thomas, Jan Moritz Middeke, Friedrich Stölzel, et al.. (2019). Reliable isolation of human mesenchymal stromal cells from bone marrow biopsy specimens in patients after allogeneic hematopoietic cell transplantation. Cytotherapy. 22(1). 21–26. 2 indexed citations

15.

Stölzel, Friedrich, Michael Krämer, Raphael Teipel, et al.. (2019). Radioimmunotherapy in Combination with Reduced-Intensity Conditioning for Allogeneic Hematopoietic Cell Transplantation in Patients with Advanced Multiple Myeloma. Biology of Blood and Marrow Transplantation. 26(4). 691–697. 6 indexed citations

16.

Teipel, Raphael, Uta Oelschlägel, Michael Krämer, et al.. (2018). Differences in Cellular Composition of Peripheral Blood Stem Cell Grafts from Healthy Stem Cell Donors Mobilized with Either Granulocyte Colony-Stimulating Factor (G-CSF) Alone or G-CSF and Plerixafor. Biology of Blood and Marrow Transplantation. 24(11). 2171–2177. 24 indexed citations

17.

Middeke, Jan Moritz, Friedrich Stölzel, Martin Wermke, et al.. (2018). Validation of the Revised Pretransplant Assessment of Mortality Score in Patients with Acute Myelogenous Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 24(9). 1947–1951. 3 indexed citations

18.

Teipel, Raphael, Falk Heidenreich, Julia Reinhardt, et al.. (2016). Durable responses to ibrutinib in patients with relapsed CLL after allogeneic stem cell transplantation. Bone Marrow Transplantation. 51(6). 793–798. 11 indexed citations

19.

Tunger, Antje, Raphael Teipel, Rebekka Wehner, et al.. (2016). Longitudinal analyses of leukemia-associated antigen-specific CD8+ T cells in patients after allogeneic stem cell transplantation. Experimental Hematology. 44(11). 1024–1033.e1. 4 indexed citations

20.

Teipel, Raphael, Johannes Schetelig, Michael Krämer, et al.. (2015). Prediction of hematopoietic stem cell yield after mobilization with granulocyte–colony‐stimulating factor in healthy unrelated donors. Transfusion. 55(12). 2855–2863. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact